VMK, Thanks for the post. In the interest of fairness I have some experience in enterprise SaaS software, having spent 15+ years in a NYC fintech startup that was eventually taken out in a trade sale. We filed an S1 though never listed. We had pricing power so * never offered trials. Offering trials doubles or triples sales cycles and there is only downside to doing so * rarely discounted (other than EOQ or EOY as you mention) * Billed up front on contract signing and if delayed payment then linked to milestones that we controlled (and not the client).
The product solved a regulatory issue so we were in this enviable position. LVT clearly isn't. That isn't the end of the world though it explains a few things, especially in the SME market.
LVT Price at posting:
24.5¢ Sentiment: None Disclosure: Not Held
(20min delay)